Heparin can improve the viability of transfected cystic fibrosis cell lines in vitro
- 17 September 2004
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 75 (18), 2203-2216
- https://doi.org/10.1016/j.lfs.2004.04.025
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of inhaled heparin on lung function and coagulation in healthy volunteersEuropean Respiratory Journal, 2002
- The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Alters Control of Essential Fatty Acid Utilization in Epithelial CellsJournal of Nutrition, 2000
- Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitroBiochemical Journal, 1999
- Restoration of Bacterial Killing Activity of Human Respiratory Cystic Fibrosis Cells through Cationic Vector-Mediated Cystic Fibrosis Transmembrane Conductance Regulator Gene TransferHuman Gene Therapy, 1999
- Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trialThe Lancet, 1999
- A Novel Tetraester Construct That Reduces Cationic Lipid-Associated Cytotoxicity. Implications for the Onset of CytotoxicityBiochemistry, 1998
- Membrane Fusion with Cationic Liposomes: Effects of Target Membrane Lipid CompositionBiochemistry, 1997
- Current knowledge on fatty acids in cystic fibrosisProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patientsThe American Journal of Clinical Nutrition, 1995
- Functional Consequences of Abnormal Fatty Acid Profiles in Cultured Airway Epithelial CellsExperimental Lung Research, 1991